Fortress Biotech Inc FBIO:NASDAQ

Last Price$1.25Cboe Real-Time Last Sale as of 1:59PM ET 8/15/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.02(1.57%)
Bid (Size)$1.22 (200)
Ask (Size)$1.27 (300)
Day Low / High$1.19 - 1.29
Volume170.9 K
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 08/15/2022

 

Fortress Biotech Inc ( NASDAQ )

Price: $1.25
Change: -0.02 (1.57%)
Volume: 170.9 K
1:59PM ET 8/15/2022
 
 

Atossa Therapeutics Inc ( NASDAQ )

Price: $1.13
Change: +0.05 (4.63%)
Volume: 1.2 M
3:00PM ET 8/15/2022
 
 

Sesen Bio Inc ( NASDAQ )

Price: $0.72
Change: +0.02 (2.70%)
Volume: 654.2 K
2:49PM ET 8/15/2022
 
 

Actinium Pharmaceuticals Inc ( NYSE MKT LLC )

Price: $6.04
Change: +0.13 (2.20%)
Volume: 121.3 K
3:07PM ET 8/15/2022
 
 

NextCure Inc ( NASDAQ )

Price: $5.12
Change: +0.03 (0.59%)
Volume: 51.9 K
2:44PM ET 8/15/2022
 

Read more news Recent News

-- Earnings Flash (FBIO) FORTRESS BIOTECH Reports Q2 Revenue $18.9M, vs. Street Est of $23.2M
4:33PM ET 8/11/2022 MT Newswires

...

-- Earnings Flash (FBIO) FORTRESS BIOTECH Reports Q2 Loss $-0.10, vs. Street Est of $-0.08
4:32PM ET 8/11/2022 MT Newswires

...

--Ladenburg Thalmann Starts Fortress Biotech at Buy With $6 Price Target
7:03AM ET 8/04/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Fortress Biotech Names David Jin as CFO
8:43AM ET 7/22/2022 MT Newswires

Fortress Biotech (FBIO) on Friday said it appointed David Jin as chief financial officer, effective Aug. 16. Jin will also continue serving as the...

View all Commentary and Analysis

Fortress Biotech (FBIO) Investor Presentation - Slideshow
3:50PM ET 8/12/2022 Seeking Alpha

Fortress Biotech (FBIO) Reports Q2 Loss, Misses Revenue Estimates
4:45PM ET 8/11/2022 Zacks

Fortress Biotech (FBIO) delivered earnings and revenue surprises of -20% and 17.35%, respectively,...

Journey Medical Corporation (FBIO) CEO Claude Maraoui on Q2 2022 Results - Earnings Call Transcript
9:05PM ET 8/09/2022 Seeking Alpha

Stocks To Watch: Retail Heavyweights Report, Block And Moderna Events
9:27AM ET 5/14/2022 Seeking Alpha

Company Profile

Business DescriptionFortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL. View company web site for more details
Address1111 Kane Concourse
Bay Harbor Islands, Florida 33154
Phone+1.781.652.4500
Number of Employees88
Recent SEC Filing08/11/20228-K
Chairman, President & Chief Executive OfficerLindsay Allan Rosenwald
Chief Financial Officer, Secretary & TreasurerRobyn M. Hunter
Senior Vice President-Biologics OperationsGeorge C. Avgerinos
Director & Vice Chairman-Strategic DevelopmentMichael Sean Weiss

Company Highlights

Price Open$1.27
Previous Close$1.27
52 Week Range$0.77 - 3.81
Market Capitalization$134.7 M
Shares Outstanding107.7 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement11/21/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.06
Beta vs. S&P 500N/A
Revenue$26.9 M
Net Profit Margin-108.87%
Return on Equity-95.07%

Analyst Ratings as of 08/03/2022

Buy
7
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset